Guided Therapeutics Inc
GTHP
Revenue
0.00
▼-6.00k▼-100.00%
3 Months ChangeAssets
1.25M
▼-243.00k▼-16.27%
3 Months ChangeLiabilities
5.92M
▲412.00k▲7.48%
3 Months ChangeFree Cash Flow
-499.00k
▼-306.00k▼-158.55%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0001477932-24-005960
2024-08-14
Form 10-Q
ID: 0001477932-24-004869
2024-05-14
Form 10-Q
ID: 0001477932-24-002788
2023-11-13
Form 10-Q
ID: 0001477932-23-008286
2023-08-10
Form 10-Q
ID: 0001477932-23-005869
2023-05-15
Form 10-Q
ID: 0001477932-23-003493
2023-03-09
Form 8-K
ID: 0001477932-23-001383
2022-11-14
Form 10-Q
ID: 0001477932-22-008459
2022-09-15
Form 8-K
ID: 0001477932-22-006945
2022-08-15
Form 10-Q
ID: 0001477932-22-006064